PR

Pradipta Ray

Active Director Director DIN 09759119
DIN 09759119 First appointment Oct 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Pradipta Ray

Data last updated:

Pradipta Ray is a Director at Renicure Biotech Private Limited (since 2022). The company operates in Chemicals. Renicure Biotech Private Limited reported revenue of ₹58.7 Lakh (FY 2024).

DIN 09759119
Primary Designation Director
Industry Chemicals
First Appointment 07 Oct 2022
Oldest Company Age 4 yrs
Largest company Renicure Biotech Private Limited · ₹58.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Renicure Biotech Private Limited U24230WB2022PTC257655
Director07 Oct 20222022₹58.7 Lakh (FY 2024)Active

Board colleagues of Pradipta Ray

NameDINCompanyDesignation
Mousumi Ray09759120Renicure Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Renicure Biotech Private Limited
Premium access

Shareholding and investment profile for Pradipta Ray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradipta Ray

Pradipta Ray currently holds 1 directorship: Renicure Biotech Private Limited (Director, since 07 Oct 2022, revenue ₹58.7 Lakh (FY 2024)).

Pradipta Ray was first appointed on 07 Oct 2022 as Director at Renicure Biotech Private Limited.

The current boards of Pradipta Ray's companies include Mousumi Ray (Renicure Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available